GlaxoSmithKline was advised by Lazard and Morgan Stanley on its failed bid for Human Genome Sciences. Morgan Stanley also advised on the successful sale of drug management company PPD to the Carlyle Group at the end of 2011. Legal counsel on the GSK bid was provided by Cleary Gottlieb Steen & Hamilton LLP and Watchtell, Lipton, Rosen & Katz.